Catalyst Wire Dossier Catalyst Wire Dossier
EMA safety_alert · 2022-09-02

New measures to minimise risk of meningioma with medicines containing nomegestrol or chlormadinone

View source ↗

Summary

EU authorities announce new measures to minimise the risk of meningioma associated with medicines containing nomegestrol or chlormadinone.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlormadinone (chlormadinone)
  • Nomegestrol (nomegestrol)